Pmh42 - Cost-Utility Analysis of Cariprazine Compared to Risperidone Among Patients With Negative Symptoms of Schizophrenia in Selected Nordic Countries

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1677

Related search